According to Integra LifeSciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.44552. At the end of 2023 the company had a P/S ratio of 2.21.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.21 | -26.54% |
2022 | 3.01 | -18.27% |
2021 | 3.68 | -7.76% |
2020 | 3.99 | 20.93% |
2019 | 3.30 | 26.42% |
2018 | 2.61 | -17.48% |
2017 | 3.16 | -2.27% |
2016 | 3.23 | 14.03% |
2015 | 2.84 | 43.16% |
2014 | 1.98 | 8.06% |
2013 | 1.83 | 39.88% |
2012 | 1.31 | 23.67% |
2011 | 1.06 | -42.5% |
2010 | 1.84 | 19.3% |
2009 | 1.55 | 2.87% |
2008 | 1.50 | -23.85% |
2007 | 1.97 | -28.9% |
2006 | 2.77 | -22.47% |
2005 | 3.58 | -21.81% |
2004 | 4.58 | 4.4% |
2003 | 4.38 | 3.36% |
2002 | 4.24 | -41.55% |
2001 | 7.26 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.79 | 161.88% | ๐บ๐ธ USA |
Medtronic MDT | 3.28 | 126.63% | ๐ฎ๐ช Ireland |
Stryker Corporation SYK | 6.23 | 330.78% | ๐บ๐ธ USA |
Teleflex TFX | 3.28 | 126.57% | ๐บ๐ธ USA |
Cardinal Health CAH | 0.1162 | -91.96% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | 1.60 | 10.85% | ๐บ๐ธ USA |
CONMED CNMD | 1.63 | 12.61% | ๐บ๐ธ USA |